Onward with Rosie O'Donnell cover image

Dr. Daniel Rosen

Onward with Rosie O'Donnell

00:00

The Safety and Effectiveness of Wigovi

Ozempic slash wigovi, which is generically known as semaglutide, has been approved for adolescents. "It's a tricky area, especially in today's like political environment to talk about like medicating kids," she says. Wigovi was approved for adolescents 12 to 18 years old without tons of data that demonstrates safety and efficacy or that it works.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app